Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > Articles online first > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 Dec 09

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 Dec 09

DOI: 10.23736/S1824-4785.21.03432-4

Copyright © 2021 EDIZIONI MINERVA MEDICA

lingua: Inglese

Contribution of pet/mr in muskuloskeletal malignancies

Lina GARCIA-CAÑAMAQUE 1 , Caroline A. FIELD 1, Felipe S. FURTADO 2, Isabel PLAZA de las HERAS 1, Jad S. HUSSEINI 2, Rene BALZA 2, Mohamed JARRAYA 2, Onofrio A. CATALANO 2, Mercedes MITJAVILA CASANOVAS 3

1 Department of Nuclear Medicine, Hospital Universitario Madrid Sanchinarro, Madrid, Spain; 2 Department of
Radiology, Massachusetts General Hospital, Boston, MA, USA; 3 Department of Nuclear Medicine, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain


PDF


PET/MR is a promising hybrid imaging technique for evaluating musculoskeletal malignancies. Both technologies, independently are useful for evaluating this type of tumours. PET/MR has great potential combining metabolic and functional imaging PET with soft tissue contrast and multiparametric sequences of MR. In this paper we review the existing literature and discuss the different protocols, new available radiotracers to conclude with the scarce evidence available the most useful/probable indications of the PET MR for the for musculoskeletal malignancies.


KEY WORDS: Skeletal; Osseous; Metastases; Myeloma; Sarcoma; PET/MR; Galio; Fdg; Colina

inizio pagina